FindTrial
Sign In

Establishment of 2D and 3D primary cell cultures from healthy and neoplastic tissue to analyze individual disease trajectories and to investigate disease in the fields of infectiology, immunology and oncology

Establishment of 2D and 3D primary cell cultures from healthy and neoplastic tissue to analyze individual disease trajectories and to investigate disease in the fields of infectiology, immunology and oncology

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00024457
Enrollment
150
Registered
2021-02-11
Start date
2021-03-24
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C34 C15 C16 C18 C25 C50

Interventions

Group 1: Patients with histopathologically proven solid tumors undergoing elective surgery or biopsy will be included. Specimens from surgically resected cancer samples or biopsies and adjacent health

Sponsors

Charité - Universitätsmedizin Berlin, Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin (CCM/CVK) am Campus Charité Mitte
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Female and male patients with histopathologically proven lung cancer undergoing an elective surgery or biopsy

Exclusion criteria

Exclusion criteria: Histopathologically proven non lung inherent tumor

Design outcomes

Secondary

MeasureTime frame
Evaluation of individual mechanisms of disease in the fields of immunology, infectiology and oncology.—

Primary

MeasureTime frame
Success rate in the establishment of primary cell cultures and organoids—

Countries

Germany

Contacts

Public ContactClaudia Spies

Charité - Universitätsmedizin Berlin, Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin (CCM/CVK) am Campus Charité Mitte

claudia.spies@charite.de030 450 531 012

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026